University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

FIGO good practice recommendations on progestogens for prevention of preterm delivery

Simple item page
dc.contributor.authorShennan, Andrew
dc.contributor.authorSuff, Natalie
dc.contributor.authorLeigh Simpson, Joe
dc.contributor.authorJacobsson, Bo
dc.contributor.authorMol, Ben W.
dc.contributor.authorGrobman, William
dc.contributor.authorFIGO Working Group for Preterm Birth
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Women’s Health Researchen
dc.date.accessioned2021-10-06T20:47:01Z
dc.date.available2021-10-06T20:47:01Z
dc.date.issued2021-10-01
dc.descriptionFunding Information: Andrew Shennan reports payment/honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Manipal India; support for attending meetings and/or travel from Hologic; leadership or fiduciary roles in the HTA Commissioning Board UK and Action on Pre‐eclampsia charity. Natalie Suff reports no conflicts of interest. Jo Leigh Simpson reports royalties from Springer and Elsevier; consulting fees from the Illumina Clinical Expert Panel 2020; payment or honoraria for lectures, presentations, speakers bureaus, or educational events from the 1 and 2 International Congresses on the Future of Women's Health, and a speaker's bureau at ASRM 2019; participation on a data safety monitoring board or advisory board for the FDA DSMB; and leadership or fiduciary roles in IFFS and PGDIS. Bo Jacobbson reports research grants from Swedish Research Council, Norwegian Research Council, March of Dimes, Burroughs Wellcome Fund and the US National Institute of Health; clinical diagnostic trials on NIPT with Ariosa (completed), Natera (ongoing), Vanadis (completed) and Hologic (ongoing) with expendidures reimbused per patient; clinical probiotic studies with product provided by FukoPharma (ongoing, no funding) and BioGaia (ongoing; also provided a research grant for the specific study); collaboration in IMPACT study where Roche, Perkin Elmer and Thermo Fisher provided reagents to PLGF analyses; coordination of scientific conferences and meetings with commercial partners as such as NNFM 2015, ESPBC 2016 and a Nordic educational meeting about NIPT and preeclampsia screening. Bo Jacobbson is also Chair of the FIGO Working Group for Preterm Birth and the European Association of Perinatal Medicine's special interest group of preterm delivery; steering group member of Genomic Medicine Sweden; chairs the Genomic Medicine Sweden complex diseases group; and is Swedish representative in the Nordic Society of Precision Medicine. Ben W. Mol reports an investigator grant from NHMRC; consultancy for ObsEva; and research funding from Guerbet, Ferring, and Merck KGaA. William A. Grobman reports no conflicts of interest. st nden
dc.description.statusPeer revieweden
dc.format.extent3
dc.format.extent336854
dc.identifier201501014
dc.identifier85d91cb2-b9bb-48f4-a8f3-2d0b43b86c43
dc.identifier85115098118
dc.identifier.citationShennan, A, Suff, N, Leigh Simpson, J, Jacobsson, B, Mol, B W, Grobman, W & FIGO Working Group for Preterm Birth 2021, 'FIGO good practice recommendations on progestogens for prevention of preterm delivery', International Journal of Gynecology and Obstetrics, vol. 155, no. 1, pp. 16-18. https://doi.org/10.1002/ijgo.13852en
dc.identifier.doi10.1002/ijgo.13852
dc.identifier.iss1en
dc.identifier.issn0020-7292
dc.identifier.otherJisc: 7f1d01a12b45470fbe8cdf62472c9c7e
dc.identifier.urihttps://hdl.handle.net/2164/17277
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85115098118&partnerID=8YFLogxKen
dc.identifier.vol155en
dc.language.isoeng
dc.relation.ispartofInternational Journal of Gynecology and Obstetricsen
dc.subjectantenatalen
dc.subjectchild outcomeen
dc.subjectpreterm deliveryen
dc.subjectpreventionen
dc.subjectprogesteroneen
dc.subjectR Medicineen
dc.subjectObstetrics and Gynaecologyen
dc.subject.lccRen
dc.titleFIGO good practice recommendations on progestogens for prevention of preterm deliveryen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Shennan_etal_OG_FIGO_good_practice_VOR.pdf
Size:
328.96 KB
Format:
Adobe Portable Document Format
Download

Collections

All research